Literature DB >> 9774198

Role of cyclic nucleotide phosphodiesterases in ischemic preconditioning.

A Lochner1, S Genade, E Tromp, L Opie, J Moolman, S Thomas, T Podzuweit.   

Abstract

Several signal transduction pathways have been implicated in the mechanism of protection induced by ischemic preconditioning (PC). For example, stimulation of a variety of G-protein coupled receptors results in stimulation of protein kinase C (PKC) which has been suggested to act as common denominator in eliciting protection. PC also significantly attenuated cAMP accumulation during sustained ischemia, suggesting involvement of an anti-adrenergic mechanism. The aim of this study was to evaluate the beta-adrenergic signal transduction pathway (as evidenced by changes in tissue cAMP and cAMP- and cGMP-phosphodiesterase) during the PC protocol as well as during sustained ischemia. Isolated perfused rat hearts were preconditioned by 3 x 5 min global ischemia (PC1,2,3) interspersed by 5 min reperfusion, followed by 25 min global ischemia. Tissue cAMP- and cGMP-PDE activity as well as cAMP and cGMP levels were determined at different time intervals during the PC protocol and sustained ischemia. Tissue cAMP increased with each PC ischemic event and normalized upon reperfusion, while PDE activity showed the opposite, viz a reduction during ischemia and an increase during reperfusion. Except for PC1, tissue cGMP showed similar fluctuations. Throughout 25 min sustained ischemia, cAMP- and cGMP-PDE activities were higher in PC than in nonpreconditioned hearts, associated with a significantly lesser accumulation in cAMP and higher cGMP levels in the former. Fluctuations in cyclic nucleotides during preconditioning were associated with concomitant changes in PDE activity, while the attenuated beta-adrenergic response of preconditioned hearts during sustained ischemia may partially be due to increased PDE activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774198

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  25 in total

Review 1.  Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors.

Authors:  J A Beavo; D H Reifsnyder
Journal:  Trends Pharmacol Sci       Date:  1990-04       Impact factor: 14.819

Review 2.  Role of protein kinase C in ischemic preconditioning: player or spectator?

Authors:  G Brooks; D J Hearse
Journal:  Circ Res       Date:  1996-09       Impact factor: 17.367

Review 3.  Nitric oxide and cardiac function.

Authors:  R A Kelly; J L Balligand; T W Smith
Journal:  Circ Res       Date:  1996-09       Impact factor: 17.367

Review 4.  Cyclic GMP and mechanisms of vasodilation.

Authors:  T M Lincoln
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

Review 5.  Possibilities for the pharmacological exploitation of ischaemic preconditioning.

Authors:  J R Parratt
Journal:  J Mol Cell Cardiol       Date:  1995-04       Impact factor: 5.000

Review 6.  Regulation of calcium slow channels of heart by cyclic nucleotides and effects of ischemia.

Authors:  N Sperelakis
Journal:  Adv Pharmacol       Date:  1994

7.  Isoproterenol mimics calcium preconditioning-induced protection against ischemia.

Authors:  H Miyawaki; M Ashraf
Journal:  Am J Physiol       Date:  1997-02

8.  Ischemic preconditioning is associated with a delay in ischemia-induced reduction of beta-adrenergic signal transduction in rabbit hearts.

Authors:  T Iwase; T Murakami; T Tomita; S Miki; K Nagai; S Sasayama
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

9.  Transient ischemia reduces norepinephrine release during sustained ischemia. Neural preconditioning in isolated rat heart.

Authors:  M Seyfarth; G Richardt; A Mizsnyak; T Kurz; A Schömig
Journal:  Circ Res       Date:  1996-04       Impact factor: 17.367

10.  Ischemic preconditioning protects against infarction in rat heart.

Authors:  Y Liu; J M Downey
Journal:  Am J Physiol       Date:  1992-10
View more
  10 in total

Review 1.  The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism.

Authors:  Javier Inserte; David Garcia-Dorado
Journal:  Br J Pharmacol       Date:  2015-03-16       Impact factor: 8.739

2.  Cardioprotection induced by olprinone, a phosphodiesterase III inhibitor, involves phosphatidylinositol-3-OH kinase-Akt and a mitochondrial permeability transition pore during early reperfusion.

Authors:  Shinya Tosaka; Tetsuji Makita; Reiko Tosaka; Takuji Maekawa; Sungsam Cho; Tetsuya Hara; Hiroyuki Ureshino; Koji Sumikawa
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

3.  Repetitive preischemic infusion of phosphodiesterase III inhibitor olprinone elicits cardioprotective effects in the failing heart after myocardial infarction.

Authors:  Yukiya Nomura; Hitoshi Horimoto; Shigetoshi Mieno; Ken-ichi Nakahara; Hirohisa Okawa; Masataka Yoshida; Sasaki Shinjiro
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

4.  Cyclic nucleotide phosphodiesterase 3A1 protects the heart against ischemia-reperfusion injury.

Authors:  Masayoshi Oikawa; Meiping Wu; Soyeon Lim; Walter E Knight; Clint L Miller; Yujun Cai; Yan Lu; Burns C Blaxall; Yasuchika Takeishi; Jun-ichi Abe; Chen Yan
Journal:  J Mol Cell Cardiol       Date:  2013-08-27       Impact factor: 5.000

Review 5.  Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling.

Authors:  D S Burley; P Ferdinandy; G F Baxter
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

Review 6.  Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts.

Authors:  Yuan James Rao; Lei Xi
Journal:  Acta Pharmacol Sin       Date:  2008-12-08       Impact factor: 6.150

7.  The Golgi apparatus is a functionally distinct Ca2+ store regulated by the PKA and Epac branches of the β1-adrenergic signaling pathway.

Authors:  Zhaokang Yang; Hannah M Kirton; David A MacDougall; John P Boyle; James Deuchars; Brenda Frater; Sreenivasan Ponnambalam; Matthew E Hardy; Edward White; Sarah C Calaghan; Chris Peers; Derek S Steele
Journal:  Sci Signal       Date:  2015-10-13       Impact factor: 8.192

8.  Long-term consumption of an obesogenic high fat diet prior to ischemia-reperfusion mediates cardioprotection via Epac1-dependent signaling.

Authors:  F Edland; A Wergeland; R Kopperud; K S Åsrud; E A Hoivik; S L Witsø; R Æsøy; L Madsen; K Kristiansen; M Bakke; S O Døskeland; A K Jonassen
Journal:  Nutr Metab (Lond)       Date:  2016-11-28       Impact factor: 4.169

Review 9.  Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth.

Authors:  Nathan A Holland; Jake T Francisco; Sean C Johnson; Joshua S Morgan; Troy J Dennis; Nishitha R Gadireddy; David A Tulis
Journal:  J Cardiovasc Dev Dis       Date:  2018-01-23

Review 10.  Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.

Authors:  A Lochner; E Marais; S Genade; B Huisamen; E F du Toit; J A Moolman
Journal:  Cardiovasc J Afr       Date:  2009 Jan-Feb       Impact factor: 1.167

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.